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Abstract
Purpose The incidence of GER, related symptoms and
complications in patients treated for congenital diaphrag-
matic hernia (CDH) are poorly defined. The aim was to
evaluate incidence and development of GER in children
treated for CDH in a short- and long-term follow-up period,
identifying potential risk factors of morbidity.
Methods Thirty-six patients were evaluated with pH-MII
at a median age of 6 months (T1) and re-evaluated with
pH-MII and endoscopy at a median age of 5 years (T2).
Results The incidence of reflux was 83 % in T1 and 61 %
in T2; the incidence of symptoms was 62 % in T1 and
38 % in T2. In both groups the reflux was mainly non-
acidic. Patch, intrathoracic stomach and esophageal
dysmotility were risk factors for GER.
Conclusions The incidence of GER and symptoms
decrease over the time but it was higher than in the liter-
ature, probably because it is mainly non-acidic and
evaluable only with MII. The esophageal dysmotility was
found to be the main risk factor. An high incidence of
reflux and esophagitis was found also in asymptomatic
patients, and so a close follow-up is recommended in all
patients even if it is asymptomatic.
Keywords Congenital diaphragmatic hernia 
Gastroesophageal reflux disease  Esophageal dysmotility 
Multichannel intraluminal impedance  Endoscopic
esophagitis
Introduction
Congenital diaphragmatic hernia (CDH) is a life-threaten-
ing congenital anomaly, occurring in 1 on 2,500 live births
approximately. Despite advances in antenatal diagnosis and
postnatal management, mortality rate remains elevated.
Traditionally, most attention has been focused on therapies
that reduce perinatal and neonatal mortality, whereas few
studies have focused on chronic morbidity and long-term
outcome. In fact, follow-up of infants treated for CDH
shows many complications [1].
Gastroesophageal reflux (GER) is one of the major
sequelae in infants who survive congenital diaphragmatic
hernia repair. The causal linkage between CDH and GER
remains unclarified and several possibilities have been
suggested. Stolar et al. [2] described a foregut dysmotility
probably related to the translocation of the stomach into the
chest, with kinking and obstruction of the gastroesophageal
junction. High incidence of non-acidic GER and impaired
esophageal motility that involve distal esophagus have
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been previously reported in our other study in patients with
CDH: a more impaired esophageal motility is closely
related to more altered GER parameters [3]. GER seems to
depend on the size of the defect and also, use of patch in
large CDH can be considered a risk factor for GER [4].
However, several authors suggested that the diaphragmatic
patch may lower the tension on the crura and then protect
from GER onset [5]. The real incidence of GER, related
symptoms and complications in children treated for CDH
are still poorly defined.
Multichannel intraluminal impedance (MII) has recently
been added to the repertoire of tests available to study both
gastroesophageal reflux and esophageal motility in pedi-
atric patients [6–10].
The aim of this study was to assess with pH-MII the
incidence and the development of GER, GER-related
symptoms and GER complications, in a population of
children treated for CDH in a short- and long-term follow-
up period, identifying potential risk factors of morbidity.
Materials and methods
Patients
Thirty-six patients (22 females and 14 males), who
underwent surgical repair for CDH between 2004 and
2007, were included in the study. All patients were eval-
uated clinically and studied with 24 h pH-Multichannel
Intraluminal Impedance (pH-MII) at a median age of
6 months (range 4–8 months), to estimate the short-term
incidence of symptoms and GER (T1 group); all patients
were re-evaluated at a median age of 5 years (range
36–84 months) with pH-MII and esophageal endoscopy, to
study the esophageal motility, the long-term incidence of
symptoms, GER and esophagitis (T2 group). Symptoms
and thoracic deformities were appraised during the clinical
examination. Chest X-ray was performed at 6 months and
5 year of age in all patients to rule out hernia recurrence
[11]. We excluded the patients who did not complete the
follow-up from the study.
All patients had a left-sided diaphragmatic defect and were
operated on with a left subcostal laparotomy. Twelve patients
(33 %) received a diaphragmatic patch (Goretex), because of
the big size of the defect. In 6/24 patients, who had primary
closure, the suture of the diaphragmatic defect was performed
under mild tension. In 26 patients (72 %) an intrathoracic
stomach was found at the time of surgery. All patients
requiring patch showed the intrathoracic herniation of the
stomach, except one patient affected by a large isolated lateral
defect only with involvement of the small bowel and spleen.
No patient required preoperative extracorporeal mem-
brane oxygenation (ECMO). No patient had other major
anomalies and underwent antireflux surgery at the time of
the first evaluation (T1). All children were admitted to our
Unit on the day of the procedure and discharged the fol-
lowing day. No patient was taking medications influencing
esophageal motor function or acidic secretion at the time of
the evaluation. Parents were asked to sign an informed
consent before every procedure and regarding the inclusion
in the study; details that might disclose the identity of the
subjects under study were omitted.
Procedure
All patients underwent 24 h combined esophageal pH/MII
monitoring, using hardware and software by Sandhill
Technologies (Sandhill Scientific). The procedure was per-
formed with age-appropriate probes with six impedance
channels. Parents were asked to fill a diary during the pro-
cedure to record the exact time of every meal, body position
and symptoms. In T2 group; before removing the probe,
when the patients were calmer and collaborating, motility
analysis was performed. In the orthostatic position, children
were given ten swallows of 5 mL of normal saline (stan-
dardized impedance value) each 20–30 s apart. The tracings
were revised visually and manually for reflux and motility
parameters as previously described [3]. We analysed reflux
parameters: number of reflux episode, both acid and non-
acid, and their height, number of pH only reflux and re-reflux,
number of long reflux ([3 min), the Bolus Exposure Index
(BEI) as main reflux index because is independently from
pH, the reflux index (RI) as acid exposure index, the activity
of acid and bolus clearance (MACT and MBCT respec-
tively). As motility parameters we analysed the following:
bolus presence time for every channel (BPT) and total and
segmental transit time (TBTT and STT respectively).
Statistical analysis
Statistical analysis of quantitative and qualitative data,
descriptive statistics included, was performed for all the
items. Continuous data were expressed as mean ± stan-
dard deviation, unless otherwise specified.
Frequency analysis was performed with Chi square test
to evaluate differences between patients with and without
patch and with McNemar statistic test to compare the
variables between T1 and T2 groups.
The paired Wilcoxon signed-rank test and the paired
samples Student’s t test were used to compare between T1
and T2 groups the non-parametric and parametric vari-
ables, respectively.
The one-way analysis of variance (ANOVA) was per-
formed to evaluate mean differences between patients with
and without patch.
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All p values were two-sided and p values \0.05 were
considered statistically significant.
Data were analysed by the Epi Info software (version
6.0, CDC, Atlanta, GA, US) and the SPSS Software 14.0
version (SPSS, Inc.,Chicago, Ill, US).
Results
The correlation between clinical parameters and GER was
described in Table 1.
In the T1 group (short term evaluation) GER was
observed in 83 % (30/36) of patients, with an high preva-
lence of non-acidic refluxes (80 %). Overall, of 30 patients
with GER, 66 % reported symptoms, 34 % have patch and
80 % had an intrathoracic stomach. Of all patients with
patch, 83 % showed GER which was symptomatic in
67 %. Of all patients with intrathoracic stomach, 93 %
showed GER which was symptomatic in 66 %. Symptoms
(recurrent vomiting and chronic cough) were reported by
62 % of patients. Of symptomatic patients, 91 % showed
GER, whereas 9 % reported cough not related to GER; of
asymptomatic patients, 72 % showed GER.
In the T2 group (long term evaluation) the incidence of
GER was 61 % (22/36 pts) with a preponderance of non-
acidic reflux (60 %). Overall, of 22 patients with GER,
54 % reported symptoms, 45 % have patch and 82 % had
intrathoracic stomach. Of all patients with patch, 50 %
showed GER and they are all symptomatic. Of all patients
with intrathoracic stomach, 69 % showed GER, 55 % of
which symptomatic. Symptoms (epigastric pain, chronic
cough, recurrent bronchitis) were reported by 38 % of
patients; 86 % of symptomatic patients showed GER,
whereas 2 patients reported cough not related to GER;
45 % of asymptomatic patients showed GER.
Impedance parameters were described in Table 2: no
statistically significant differences between the two groups
were found, except for number and height of non-acidic
reflux. The GER parameters were related to the patch in
Table 3: patients with patch showed parameters of reflux
more altered than patients without patch in both group.
Regarding the motility analysis in T2 group, parameters of
esophageal motility resulted more altered than values
reported in healthy children [9] with more prolonged total
and segmental transit time (Table 4). The Bolus Exposure
Index (BEI) was related to the presence of patch, esopha-
gitis and transit time: higher values of BEI were found in
patients with esophagitis, patch and a more prolonged
transit time (Table 5).
In both groups more than 80 % of reflux episode were
short (\3 min) and occurred in the postprandial period.
In T2 group esophagitis was found in 36 % of patients
with GER: the 50 % of these patients were asymptomatic
and without patch. The 50 % of these patients was sub-
mitted on antireflux surgery, whereas the other patients
responded to medical treatment.
Thoracic deformities were recorded in 16 % of patients;
all these patients underwent closure of the diaphragmatic
defect under tension without patch and developed a severe
GER.
Recurrence of diaphragmatic hernia was observed in
5 % of patients in T2 group and they subjected to a second
surgical procedure. No recurrence of hernia was found in
T1 group.
Table 1 Compared results
between the two groups:
correlation between clinical
parameters and GER
Legend of symptoms: T1 group:
recurrent vomiting and chronic
cough. T2 group: epigastric
pain, chronic cough and
recurrent bronchitis
No. number, GER
gastroesophageal reflux
* p \ 0.05
T1 Group % (no. of patients) T2 Group % (no. of patients)
Patients GER? 83 (30/36) 61 (22/36)*
Symptomatic 66 54
Asymptomatic 34 46*
Patch? 34 45*
Intrathoracic stomach? 80 82
Patients with patch 33 (12/36) 33 (12/36)
GER? 83 50*
GER ? symptomatic 67 100*
Patients with intrathoracic stomach 72 (26/36) 72 (26/36)
GER? 93 69*
GER ? symptomatic 66 55
Symptomatic patients 62 (22/36) 38 (14/36)*
GER? 91 86
GER- 9 14
Asymptomatic patients 38 (14/36) 62 (22/36)*
GER? 72 45*
GER- 28 55*
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Discussion
Gastroesophageal reflux (GER) is common after congenital
diaphragmatic hernia repair.
The incidence of GER varies according to used diagnostic
criteria: symptoms, radiologic findings, pH-metry or endos-
copy. It may occur in 30–70 % of patients [12, 13], but an
incidence of up to 80 % has been reported in patients treated
with ECMO before CDH repair [14]. It is also reported that
15–70 % of CDH patients remains symptomatic under
medical treatment, and thus requires fundoplication [14–
16]. The incidence and the severity of GER symptoms,
however, decrease after the first year of life [12]. GER is an
important parameter of overall short- and long-term mor-
bidity even if the mechanism responsible, either intrinsic or
extrinsic, is still unclear [17–19]. On endoscopy an alarming
finding, such as Barrett’s esophagus, was observed and
recently CDH survivors with esophageal adenocarcinoma
have been described [20]. For these reasons patients with
CDH require a close surveillance.
Our study assesses the incidence and pattern of GER
using pH-MI in a population of children treated for CDH at
birth, evaluated at 6 months and 5 years of age; the anal-
ysis of the same patients over the time implies a high
statistical significance of the obtained results. We also
evaluated the correlation between GER and esophageal
motility, in addition to the main risk factors as described in
the literature (patch repair and intrathoracic stomach).
Moreover, complications such as esophagitis, thoracic
deformities and hernia recurrence were estimated.
Our results confirm that, even in patients with CDH, the
incidence of GER decreases over the time, varying from
83 % in the T1 group to 61 % in the T2 group, however,
remaining elevated. The incidence of GER reported in this
series, as in our previous studies, resulted higher than that
reported in the literature [12, 13]; this may probably due to
the high incidence of non-acidic reflux, which is not
detectable using conventional pH-metry. No differences
were found considering reflux parameters in the two groups
except for number of non-acidic reflux (Table 2); this
means that the severity of reflux does not change over the
time because only this value does not seem sufficient to
influence the severity of reflux. Interestingly, high inci-
dence of GER was found also in asymptomatic patients in
both groups (72 and 45 % in T1 and T2 groups, respec-
tively); furthermore, among patients with GER, the inci-
dence of asymptomatic cases increased in T2 group (34 vs
46 %) (Table 1).
Koivusalo described a positive development of symp-
toms [12] and the same was also noted in our series: 45 %
of symptomatic patients of T1 group healed, whereas 55 %
remained symptomatic at the second evaluation (T2
group); however, 14 % of patients who were asymptomatic
in T1 evaluation became symptomatic in T2. As for the
evolution of GER, 33 % of patients healed in T2 evalua-
tion, whereas 67 % continued to have GER.
A detailed statistical analysis was conducted about the
relationship between the use of patch and GER. Patients
with patch reported a more altered reflux parameters if
compared with patients without patch; no statistically sig-
nificant differences were found between patients with and
without patch regarding to the incidence of reflux. Hence, it
is likely that the presence of patch influences the severity of
reflux without affecting its incidence and that the severity
of reflux does not change over the time. The percentage of
patients with patch who develop GER decreased during
years (83 vs 50 % in T1 and T2 groups, respectively);
however, among patients with GER, the percentage of
Table 2 Impedance parameters in the two groups
Impedance parameters T1 Group (mean ± SD) T2 Group (mean ± SD) p
Incidence of GER (%) 83.3 61.1 0.528
No. of tot of GER 71.7 ± 33.2 60.6 ± 44.5 0.191
No. of acidic GER 21.1 ± 25.5 21.1 ± 30.9 0.99
No. of non-acidic GER 50.6 ± 31.7 39.9 ± 34.0 0.031
No. of high non-acidic GER 17.7 ± 12.8 8.61 ± 15.2 0.006
No. of high acidic GER 9.7 ± 16.7 18.6 ± 29.0 0.22
No. of pH only reflux 2.89 ± 4.2 2.89 ± 4.7 1.00
No. of re-reflux 2.1 ± 3.4 1.8 ± 3.5 0.651
BEI (%) 4.2 ± 1.9 3.6 ± 2.4 0.246
RI (%) 4.8 ± 5.0 4.5 ± 6.0 0.864
MACT (s) 106.0 ± 59.5 118.0 ± 86.9 0.565
MBCT (s) 45.2 ± 21.4 47.8 ± 32.8 0.735
No. number, tot total, GER gastroesophageal reflux, BEI Bolus Exposure Index, RI reflux index, MACT mean acid clearance time, MBCT mean
bolus clearance time
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those with patch increased in the T2 group (33 vs 45 %).
Most of the patients with patch were asymptomatic in both
groups; however, patients with patch had higher incidence
of symptoms if compared with patients without patch.
On the basis of our results, we can confirm that patch is
a risk factor for severe GER (more altered impedance
parameters) and it influences the onset of symptoms, as
recently described [21, 22]. Also the closure of the dia-
phragm under tension is a risk factor for severe GER, as
previously reported by some Authors who consider that the
use of a prosthetic patch, during diaphragmatic hernia
repair, could reduce the morbidity related to GER lowering
the strain on the crura [5]. In our series, diaphragmatic
defect closure under mild tension and without patch was
observed in all patients with thoracic deformities (16 %)
and all these patients had GER.
However, our series is too small to draw definitive
conclusions about patch, even because the number of
patients with and without patch is different.
A more severely impaired esophageal motility was
observed in patients with patch, probably due to the wider
size of the diaphragmatic defect and the greater compression
Table 3 Impedance parameters in the two groups with analysis regarding patch
Impedance parameters T1 Group (mean ± SD) T2 Group (mean ± SD) p
T1 vs T2
No. of tot of GER
Patch ? 87.5 ± 40.7* 73.8 ± 61.2* 0.477
Patch - 63.9 ± 27.4 54.0 ± 34.8 0.301
No. of acidic GER
Patch ? 42.3 ± 36.9* 24.5 ± 38.6 0.28
Patch - 10.5 ± 4.5 19.5 ± 28.2 0.306
No. of non-acidic GER
Patch ? 45.1 ± 44.4 49.3 ± 45.5 0.426
Patch - 53.4 ± 25.1 34.4 ± 27.6 0.006
No. of high non-acidic GER
Patch ? 17.0 ± 18.4 17.0 ± 24.5* 1.000
Patch - 18.0 ± 9.9 4.4 ± 5.4 0.001
No. of high acidic GER
Patch ? 22.5 ± 25.3* 21.8 ± 38.3 0.28
Patch - 3.4 ± 2.7 17.0 ± 25.0 0.07
No. of pH only reflux
Patch ? 6.1 ± 6.1* 4.8 ± 7.5 0.601
Patch - 1.25 ± 1.2 1.92 ± 2.2 0.388
No. of re-reflux
Patch ? 4.67 ± 5.1* 3.3 ± 5.7 0.505
Patch - 0.92 ± 1.1 1.08 ± 1.5 0.787
BEI (%)
Patch? 5.4 ± 2.3* 4.3 ± 3.3 0.306
Patch- 3.6 ± 1.4 3.2 ± 1.9 0.576
RI (%)
Patch? 8.9 ± 7.2* 5.1 ± 7.3 0.270
Patch- 2.7 ± 1.2 4.2 ± 5.6 0.410
MACT (s)
Patch? 153.1 ± 82.9* 135.8 ± 120.1 0.688
Patch- 82.4 ± 22.9 109.1 ± 69.8 0.274
MBCT (s)
Patch? 46.8 ± 23.7 51.1 ± 36.8 0.681
Patch- 44.4 ± 21.3 46.2 ± 32.2 0.868
No. number, tot total, GER gastroesophageal reflux, BEI Bolus Exposure Index, RI reflux index; MACT mean acid clearance time, MBCT mean
bolus clearance time
* p \ 0.05 patch? vs patch–
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on the fetal esophagus, which may impair the intrinsic
innervation of the esophagus [2, 3, 19].
The esophageal dysmotility was found to be the main
risk factor for the presence, the severity and the mainte-
nance of reflux over the time. A correlation between BEI
and bolus transit time was found (Table 5): patients with
more prolonged esophageal transit time showed more
pathologic exposure bolus. Probably an impaired esopha-
geal motility influences the clearing and then the bolus
exposure; a more altered Bolus Exposure Index indicates a
pathological reflux with risk of the persistence over the
time and of esophagitis. Patients without impaired motility
have a GER without complications and may recover.
Among the patients with GER, 36 % showed esopha-
gitis on endoscopic evaluation; 50 % of these patients had
patch and they were asymptomatic. All patients with
esophagitis had more altered parameters of esophageal
motility than patients without esophagitis (Table 5).
The intrathoracic stomach was confirmed to be a risk
factor for GER, probably causing an alteration of gastro-
esophageal junction.
The incidence of recurrence in our study is very low
compared to data reported in literature [21–24], probably
due to the little use of patch and the accurate closure of
defect.
As for the length of follow-up in our series, we are
aware that 5 years are a mild term period, but pH-MII is a
recent technique and so the mean time of follow-up is
conditioned from this; further studies are necessary over
the time to establish the real long-term follow-up in these
patients using pH-MII.
In our previously published study [3], we analysed
patients with a median age of 5 years to identify for the
first time an esophageal dysmotility as yet evaluated in
patients with esophageal atresia. In this study, the objective
was different: we wanted to study the reflux and its evo-
lution over time, and so we reported the previous data
comparing them with those obtained at 6 months.
In conclusion, our results about the incidence and evo-
lution of GER suggest that a close clinical and instrumental
monitoring of patients treated for CDH is mandatory, even
in asymptomatic patients. The pH-MII is a gold standard
technique for the evaluation of patients with esophageal
and gastric malformations, because it analyses the real
incidence of GER (both acid and non-acidic) and esopha-
geal motility, identifying patients with severe GER and
dysmotility at higher risk of complications. The incidence
of complications as esophagitis does not justify antireflux
preventive surgery; in this study only medical treatment
and a close clinical and instrumental monitoring seem to be
sufficient to avoid complications in the most of cases.
Besides, we believe that CDH patients, as those treated at
birth for esophageal atresia, should start antireflux medi-
cations (antiacidic and prokinetic therapy) early in the
postoperative period and not only after the onset of GER
symptoms. Uunfortunately, the currently available proki-
netic medications have only modest efficacy in relieving
reflux symptoms, and the side effect profile of these agents
renders them a less useful clinical practice [25]. However,
we agree with some authors regarding the association
between PPI and prokinetic to improve the PPI effect [26].
In these children pH-MII shows that most refluxes are
non-acidic, short and mainly postprandial refluxes. We can,
therefore, suppose that the relaxation of the lower esoph-
ageal sphincter is the main event for the occurrence of
reflux and, therefore, the role of gastroesophageal junction
Table 4 Motility parameters in T2 Group
Motility parameters (s) Mean (±SD) (range)
SST1 2.0 (0.7) (0.6–3.5)
SST2 2.1 (0.7) (0.7–3.4)
STT3 2.4 (0.6) (0.8–3.6)
STT4 2.7 (0.7) (1.0–3.8)
STT5 3.2 (0.7) (1.4–4.0)
BPT1 4.9 (2.6) (1.5–9.2)
BPT2 5.2 (2.7) (1.3–9.3)
BPT3 6.0 (2.6) (1.9–9.5)
BPT4 6.4 (2.7) (1.7–9.7)
BPT5 7.4 (2.4) (3.3–10.2)
BPT6 8.4 (2.5) (3.6–10.7)
TBTT 9.7 (2.3) (5.6–14.2)
Mean values calculated on 10 standard swallows for all patients
STT segmental transit time, BPT bolus presence time, TBTT total
bolus transit time
Table 5 Correlation of BEI (impedance reflux parameter), TBTT
(impedance motility parameter), presence of patch and esophagitis in
randomly chosen patients of T2 group
Patient no. Patch Esophagitis BEI (%) TBTT (s)
29 ? ? 8.1 14.25
17 ? ? 7.2 13.83
4 ? ? 6.9 13.45
12 ? ? 6.8 11.6
32 - ? 4.9 10.04
9 ? ? 4.8 9.98
30 - ? 3.6 8.96
25 - - 1.3 6.14
13 - - 0.9 6.12
2 - - 1.2 6.3
35 - - 0.7 5.6
BEI Bolus Exposure Index (normal \ 1.4 %), TBTT total bolus transit
time (normal values \ 8.3 s in healthy children from J Ped Surg
2011;46:1881–1886)
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is essential [28, 29]. For these reason, meticulous attention
to the diaphragmatic crura during surgical repair is highly
recommended to minimize the risk of GER in CDH
patients. We recommend fundoplication about the IPEG
guidelines [27], although the long-term success rate of this
procedure in CDH patients has not to be proven.
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